Kidney RSS News Feeds

Nephrology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Fabrizi F et al. - The meta-analysis shows that terlipressin has higher efficacy than placebo in reversing renal function in the HRS population. There was no apparent impact of terlipressin therapy on survival in HRS patients but further large-size trials are needed. Terlipressin use in the HRS population requires careful selection of patients and close clinical surveillance. These results support the use of terlipressin for reversal of renal function in the HRS population.

   

Related Articles

Predictors of response to therapy with terlipressin and albumin in patients with cirrhosis and type 1 hepatorenal syndrome
Hepatology, 11/02/09    Relevance Score: 87%

Effects of terlipressin on systemic, hepatic and renal hemodynamics in patients with cirrhosis
Journal of Gastroenterology and Hepatology, 10/29/09    Relevance Score: 83%

Systematic review of randomized trials on vasoconstrictor drugs for hepatorenal syndrome
Hepatology, 11/04/09    Relevance Score: 80%

Today in Chronic Dz/Renal Failure...keeping you current

Coronary Calcification in Patients with Chronic Kidney Disease and Coronary Artery Disease
Clinical Journal of the American Society of Nephrology, 12/09/09

Is albuminuria associated with obesity in school children
Pediatric Diabetes, 12/09/09

Plasma and urine neutrophil gelatinase-associated lipocalin in septic versus non-septic acute kidney injury in critical illness
Intensive Care Medicine, 12/09/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address